Imagenebio Stock Investor Sentiment

IMA Stock   6.58  0.25  3.66%   
About 61% of ImageneBio's investor base is looking to short. The analysis of the overall investor sentiment regarding ImageneBio suggests that many traders are alarmed. The current market sentiment, together with ImageneBio's historical and current headlines, can help investors time the market. In addition, many technical investors use ImageneBio stock news signals to limit their universe of possible portfolio assets.
20 hours ago at globenewswire.com         
Accountants Enter 2026 Downbeat on Global Economic Prospects
Macroaxis News: globenewswire.com
2 days ago at prnewswire.com         
Breaking News IMA Senior Fellow Dr. Kimberly Biss Appointed to Advisory Committee on Immunization Pr...
prnewswire News
few days ago at thelincolnianonline.com         
ImageneBio, Inc. Receives 26.50 Consensus PT from Analysts
news
over two weeks ago at simplywall.st         
Joseph Slattery Spends US96k On ImageneBio Stock
Simply Wall St News at Macroaxis
over two weeks ago at finance.yahoo.com         
ImageneBio Insider Confidence Rewarded, Stock Hits US76m Market Cap
Yahoo News
over two weeks ago at www.macroaxis.com         
Acquisition by Erin Butler of 22500 shares of ImageneBio at 7.11 subject to Rule 16b-3
Macroaxis News
over two weeks ago at news.google.com         
Top ImageneBio Insider Makes Bold New Move on Company Stock - TipRanks
Google News at Macroaxis
over two weeks ago at www.macroaxis.com         
Acquisition by Slattery Joseph P of 16000 shares of ImageneBio at 5.99 subject to Rule 16b-3
Macroaxis News
over three weeks ago at thelincolnianonline.com         
Brokerages Set ImageneBio, Inc. PT at 26.50
news
over three weeks ago at thelincolnianonline.com         
Acquisition by Slattery Joseph P of 31200 shares of ImageneBio at 6.19 subject to Rule 16b-3
news
over a month ago at news.google.com         
ImageneBio, Inc. Given Consensus Rating of Hold by Brokerages - MarketBeat
Google News at Macroaxis
over a month ago at newswire.com         
Artful Living X IMA ART Present White-Glove Fertility
news
over a month ago at news.google.com         
Wedbush Comments on ImageneBios Q4 Earnings - MarketBeat
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
Brokerages Set ImageneBio, Inc. Target Price at 26.50
news
over a month ago at finance.yahoo.com         
Builders Launches Interactive AI Tool Ima to Give All Texans a Voice in Policymaking
Yahoo News
There is far too much social signal, news, headlines, and media speculation about ImageneBio that are available to investors today. This information is accessible both publicly - through ImageneBio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of ImageneBio-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of ImageneBio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ImageneBio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ImageneBio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ImageneBio alpha.

ImageneBio Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for ImageneBio Stock analysis

When running ImageneBio's price analysis, check to measure ImageneBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImageneBio is operating at the current time. Most of ImageneBio's value examination focuses on studying past and present price action to predict the probability of ImageneBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImageneBio's price. Additionally, you may evaluate how the addition of ImageneBio to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges